↓ Skip to main content

The effectiveness of anti–tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population‐based study

Overview of attention for article published in Arthritis & Rheumatism, December 2005
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effectiveness of anti–tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: A population‐based study
Published in
Arthritis & Rheumatism, December 2005
DOI 10.1002/art.21491
Pubmed ID
Authors

Axel Finckh, Julia F. Simard, Jeffrey Duryea, Matthew H. Liang, Jie Huang, Synove Daneel, Adrian Forster, Cem Gabay, Pierre‐André Guerne

Abstract

To compare the effectiveness of 3 therapeutic strategies in preventing progressive joint damage, in a population-based cohort. The 3 strategies were infliximab with concomitant disease-modifying antirheumatic drugs (DMARDs), etanercept with concomitant DMARDs, and etanercept alone.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Netherlands 1 2%
Germany 1 2%
Unknown 54 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 21%
Other 8 14%
Student > Ph. D. Student 8 14%
Professor 5 9%
Student > Master 5 9%
Other 10 18%
Unknown 9 16%
Readers by discipline Count As %
Medicine and Dentistry 31 54%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Agricultural and Biological Sciences 3 5%
Business, Management and Accounting 1 2%
Nursing and Health Professions 1 2%
Other 4 7%
Unknown 13 23%